TY - JOUR
T1 - Prognosis of Idiopathic Recurrent Pericarditis as Determined from Previously Published Reports
AU - Imazio, Massimo
AU - Brucato, Antonio
AU - Adler, Yehuda
AU - Brambilla, Giovanni
AU - Artom, Galit
AU - Cecchi, Enrico
AU - Palmieri, Giancarlo
AU - Trinchero, Rita
PY - 2007/9/15
Y1 - 2007/9/15
N2 - After a systematic review of all publications on recurrent pericarditis from 1966 to 2006, we identified 8 major clinical series including a total of 230 patients with idiopathic recurrent pericarditis (mean age 46 years, men/women ratio: 0.9). After a mean follow-up of 61 months, the complication rate was 3.5% cardiac tamponade and 0% constrictive pericarditis and left ventricular dysfunction. The overall life prognosis is excellent in idiopathic recurrent pericarditis and complications are uncommon. In conclusion constrictive pericarditis was never reported despite numerous recurrences, and the risk is lower than in idiopathic acute pericarditis (approximately 1%). Thus, it is important to reassure patients on their prognosis, explaining the nature of the disease, and the likely course. Therapeutic choices should take into account of the overall good outcome of these patients, including less toxic agents.
AB - After a systematic review of all publications on recurrent pericarditis from 1966 to 2006, we identified 8 major clinical series including a total of 230 patients with idiopathic recurrent pericarditis (mean age 46 years, men/women ratio: 0.9). After a mean follow-up of 61 months, the complication rate was 3.5% cardiac tamponade and 0% constrictive pericarditis and left ventricular dysfunction. The overall life prognosis is excellent in idiopathic recurrent pericarditis and complications are uncommon. In conclusion constrictive pericarditis was never reported despite numerous recurrences, and the risk is lower than in idiopathic acute pericarditis (approximately 1%). Thus, it is important to reassure patients on their prognosis, explaining the nature of the disease, and the likely course. Therapeutic choices should take into account of the overall good outcome of these patients, including less toxic agents.
UR - http://www.scopus.com/inward/record.url?scp=34548405533&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2007.04.047
DO - 10.1016/j.amjcard.2007.04.047
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 17826391
AN - SCOPUS:34548405533
VL - 100
SP - 1026
EP - 1028
JO - American Journal of Cardiology
JF - American Journal of Cardiology
SN - 0002-9149
IS - 6
ER -